Foresite Capital is a multi-stage healthcare and life sciences investment firm that uses a data science-driven approach to fund companies leveraging biology and big data to transform healthcare. The firm focuses on breakthrough opportunities at the intersection of tech and biotech, with a portfolio that includes visionary firms across various stages of their life cycles.
Recent Transactions involving Foresite Capital
| Deal | Target | Platform | Buyer | Industry |
|---|---|---|---|---|
Aetion Closes $110M Series C Funding Round Led by Warburg Pincus |
Aetion |
Warburg PincusForesite CapitalB Capital Group |
Software Development |
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →